Apogee Interactive’s Energy Forecaster Tool Increases Web Traffic and Improves Customer Satisfaction
Feb 02, 2016 12:00 pm UTC| Business
ATLANTA, Feb. 02, 2016 -- Apogee Interactive today announced that utility companies offering its online Energy Forecaster tool for estimating future energy bills are seeing a 40 percent increase in website traffic and...
OncoCyte Corporation to Present at the 2016 BIO CEO & Investor Conference
Feb 02, 2016 12:00 pm UTC| Business
ALAMEDA, Calif., Feb. 02, 2016 -- OncoCyte Corporation (NYSE:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today that William Annett, Chief Executive Officer, is...
Fall in Love With Radisson Hotel Rochester Riverside Valentine’s Day Packages
Feb 02, 2016 12:00 pm UTC| Business
ROCHESTER, N.Y., Feb. 02, 2016 -- Celebrate your love with the ultimate Valentine's Day escape at the Radisson Hotel Rochester Riverside, located in the heart of downtown Rochester. Our exclusive couples-only packages...
Feb 02, 2016 12:00 pm UTC| Business
Q1 sales increased 14% to $245.7 million driven by volume growth and acquisitionsConsumer purchases increase 14% in Q1 driven by strong fall lawn care 580 bps adjusted gross margin rate improvement due to product mix,...
Apricus Biosciences to Present at the 18th Annual BIO CEO & Investor Conference
Feb 02, 2016 12:00 pm UTC| Business
SAN DIEGO, Feb. 02, 2016 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Richard Pascoe, Chief Executive Officer,...
Feb 02, 2016 12:00 pm UTC| Business
Safe and well tolerated over two yearsHeight velocity (HV) in second year comparable to published US rhGH daily dosing data; further confirms Phase 3 dose and scheduleExtremely high rate of adherence to dosing schedule in...
Cyclacel Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference
Feb 02, 2016 12:00 pm UTC| Business
BERKELEY HEIGHTS, N.J., Feb. 02, 2016 -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of...